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Growth and differentiation of the mammary gland are 
dependent on the actions of a number of hormones acting in con­
cert throughout pregnancy and lactation. Lactogenesis, in 
particular, is controlled by changes in the hormonal environ­
ment at the time of parturition and is characterized by an in­
crease in ribonucleic acid (RNA) and the ribonucleic acid to 
deoxyribonucleic acid (RNA;DNA) ratio (Denamur 1974), lactose 
(Shinde et al. 1965; Kuhn and Lowenstein 1967), a-lactalbumin 
(Kuhn 1968), casein (Liu and Davis 1967) and fatty acid 
synthesis (Patton and Hood 1969). Also, the onset of lacta-
tation is preceded by a sharp increase in the activities of many 
enzymes (Baldwin and Milligan 1966). 
DNA synthesis has been reported by several workers to con­
tinue into the first few days of lactation (Griffith and 
Turner 1961; Greenbaum and slater 1957; Kunford 1963; Traurig 
1967) supporting the idea of a wave of cell proliferation in 
the mammary gland beginning at parturition and continuing 
through the first 3 days of lactation (Greenbaum and Slater 
1957). 
In spite of the fact that there is a great deal of infor­
mation available on the hormonal requirements for mammogenesis, 
lactogenesis and galactopoiesis, the cellular mechanisms of hor­
monal stimulation involved are not clearly understood. Cyclic 
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adenosine 3',5' -monophosphate (cyclic AMP) has been implicated as a 
a second messenger in hormonal stimulation (Sutherland et al. 
1965) and has been implicated in the modification of nuclear 
proteins resulting in changes in the rate of synthesis of 
multiple classes of RNA (Jost and Sahib 1971). Majumder and 
Turkington (1971b) reported two protein kinases from mouse 
mammary cells, one of which was activated by cyclic AMP. 
Sapag-Hagar and Greenbaum (1973) reported changes in 
rat mammary gland cyclic AMP, phosphodiesterase and adenylate 
cyclase activities during pregnancy and lactation. Peak 
activities of adenylate cyclase and cyclic AMP were reported 
on the 20th day of pregnancy while activities were found to 
decline throughout lactation. Phosphodiesterase activities 
were low during pregnancy and high during lactation. Subse­
quently, Sapag-Hager et al. (1974) reported the inhibition 
of DNA, RNA and fatty acid synthesis in rat mammary organ 
cultures incubated in Medium 199 containing 10"^ M dibutyrl 
cyclic AMP. 
Recently, Goldberg et al. {1973a,b) have presented evidence 
for a reciprocal relationship betv/een cyclic AMP and cyclic 
guanosine 3',5'-monophosphate (cyclic GMP) in a number of 
experimental situations. Of particular interest were reports 
that high cyclic AMP levels are capable of inhibiting cell 
proliferation (Abe11 and Monahan 1973; Otten et al. 1971) and 
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that an increase in cyclic GMP was observed in mitogenic stimu­
lated proliferation of human blood lymphocytes (Hadden et al. 
1972). 
Since cyclic GMP levels have not been reported for rat 
mammary tissue, it was thought desirable to evaluate both 
cyclic AMP and cyclic GMP levels in relation to DNA and RNA 
levels in mammary glands of pregnant and lactating rats in 
hopes of attaching some significance to the levels of these 
cyclic nucleotides in relation to proliferation and protein 
synthetic capabilities of the gland. It was also thought 
important to determine if the cyclic nucleotides in the mammary 
gland were related in a reciprocal manner, according to the 




The hormonal factors influencing mammogenesis have been 
extensively studied both in vivo and ^  vitro and have been 
the subject of many reviews (Lyons, Li and Johnson 1958; 
Jacobsohn 1961; Cowie 1966; Turner 1970; Anderson 1974; Ceriani 
1974; Porter 1974). The following is a brief review of the 
development of the functional lactating mammary gland. 
Pregestational development 
The mammary glands develop from the embryonic region known 
as the mammary band. Mammary buds develop from the Malpighian 
layer of the skin and differentiate into primary and secondary 
sprouts. In the female, the secondary sprouts form the basis 
of the functional duct system. Post partum growth, prior to 
puberty.- is primarily characterized by an increase in connective 
tissue and fat deposition. A period of isometric growth pre­
cedes a period of allometric development where mammary gland 
growth rate exceeds the rate of increase in body surface area. 
This change from isometric to allometric growth occurs approxi­
mately at the time of weaning and well before the onset of 
puberty. Castration prevents allometric growth suggesting that 
ovarian steroids are important during this stage. After 
puberty, further development characterized by branching and re­
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branching of the ductal network takes place with each recurring 
estrous cycle. Maximal virginal development of the mammary 
glands in rats is usually obtained by the fourth estrous cycle 
and further development requires the altered hormonal environ­
ment of pregnancy (Anderson 1974), 
Mammoqenesis during pregnancy 
With the onset of pregnancy the mammary gland of the 
rat undergoes a sequential transformation characterized by 
proliferation of the ductal network, differentiation of the 
epithelium to form the secretory cell clusters at the termina­
tions of the ducts, and milk synthesis. Proliferation of the 
mammary gland during pregnancy occurs primarily in the paren­
chymal portion of the gland and at the cost of the fat pad 
(Harkness and Harkness, 1956; Paape and Sinha 1971). 
Originally, cellular proliferation of the mammary gland 
was thought to be complete during the first half of gestation 
(Weatherford 1929; Turner and Schultze 1931). This was chal­
lenged by Jeffers in 1935 and in more recent studies which 
demonstrated that cellular proliferation continued throughout 
pregnancy and into the first few days of lactation (Greenbaum 
and Slater 1957; Griffith and 'Turner 1961; Munford 1963; 
Traurig 1967). Greenbaum and Slater (1957) observed a doubling 
of total mammary gland DNA between parturition and day 3 of 
lactation, while Griffith and Turner (1961) reported that 
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greater than 40 per cent of the mammary gland development 
occurred during early lactation. Traurig (1967) found sig­
nificant incorporation of tritiated thymidine into mammary 
gland DNA on days 2 and 3 of lactation. These later studies 
support the idea that there is a wave of epithelial cell 
proliferation occurring in the mammary gland after parturition 
during early lactation. 
Hormonal factors 
The hormonal control of mammogenesis during pregnancy is 
complex and involves the interaction of many hormones. 
The ovarian steroids were the first hormones to be studied 
in relation to mammary gland development. In rats and mice, 
estrogen stimulates ductal proliferation while progesterone, 
in the presence of small amounts of estrogen, is necessary 
for lobuloalveolar growth (Turner 1939; Moon et al. 1959). 
Several investigators pointed out the importance of the 
hormones of the anterior pituitary gland in mammogenesis when 
they demonstrated that ovarian steriods failed to have a mam-
mogenic influence in hypophysectomized rats and mice (Nelson 
and Tobin 1936; Reece, Turner and Hill 1936; Selye and Collip 
1936). Nathanson et al. (1339) and Reece and Leonard (1941) 
subsequently demonstrated mammary gland duct growth in hypo­
physectomized rats injected with estrogen and "crude" pitui­
tary extracts. 
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Extensive work by Lyons, Li and Johnson (1958) helped to 
emphasize the broad base of hormonal support the mammary 
gland receives in its development. In triply operated (hypo-
physectomized-adrenalectomized-ovariectomized) rats they 
demonstrated that estrogen, growth hormone (GH) and adrenal 
steroids were necessary for duct growth and that lobuloalveolar 
development was dependent upon the addition of progesterone 
and prolactin to the aforementioned complex. 
The placenta may play an important role in mammogenesis 
during the last half of gestation in the rat. Matthies (1967) 
demonstrated the presence of a substance(s) in the tropho­
blastic elements of the midgestational rat placenta possessing 
luteotropic and mammotropic properties which he called rat 
chorionic mammotropin (RCM), Furthermore, Cohen and Gala 
(1969) demonstrated luteotropic activity, which they at­
tributed to RCM, in the serum of pregnant rats on the 12th 
day of gestation, but they determined that the mammotropic 
activity of this serum was modest, at best, and was incapable 
of inducing secretory activity. 
Lactational Development and Lactogenesis 
The initiation of lactation (lactogenesis) is character­
ized by a sudden increase in the secretory activity of the 
epithelial cells brought forth by the complex interaction of 
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hormonal and neural stimulation occurring around the time of 
parturition (Cowie 1969; Denamur 1971; Kuhn 1971; Tucker 1974). 
Hormonal factors 
The current concept of a triggering mechanism for lacto-
genesis involves removal of the progesterone block at par­
turition and the positive stimulus of the "lactogenic complex" 
from the anterior pituitary (cowie 1969). 
In the rat, hypophysectomy causes the cessation of milk 
synthesis (Selye et al. 1933) and reduces mammary cell numbers, 
DNA, RNA and several enzymes essential for milk synthesis 
(Baldwin and Martin 1968). Hormonal replacement studies in 
hypophysectomized rats demonstrated that prolactin and adre­
nocorticotropic hormone (ACTH) or adrenal corticoids are re­
quired for initiation and for maintenance of lactation (Nelson 
et al. 1943; Bintarningsih et al. 1957, 1958; Cowie 1957). 
Lyons, Li and Johnson (1958), working with the triply operated 
rat found that prolactin (mammotropin) and adrenal corticoid 
were the hormones necessary for lactational development, al­
though somatotropin and thyroxine enhanced the action of the 
former two hormones. 
Barrena (1975) has reported that adrenalectomy in rats on 
day 18 of pregnancy caused a significant reduction in mammary 
. cell size and RNA:DNA ratios when compared to controls sacri­
ficed on the 22nd day of pregnancy. Davis and Liu (1969) have 
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demonstrated that adrenalectomy on the 14th day of pregnancy 
inhibits secretion of casein-like material in the mammary 
glands of rats in which lactation was experimentally induced 
by ovariectomy. 
Biologically active corticosteriods may be present at 
too low a level during pregnancy, due to the presence of high 
circulating levels of corticosteriod binding globulin (CBG) 
to allow for milk secretion. Gala and Westphal (1965) noted 
a precipitous drop in CBG activity of rat serum from day 20 
of pregnancy to day 3 of lactation and postulated that this 
decrease in CBG resulted in an increase in free corticosteriod 
which is important for initiation and maintenance of lacta­
tion. 
It is thought that estrogen and progesterone render 
the mammary gland secretory cells refractory to stimulation 
by prolactin and adrenal corticoids during pregnancy. 
The combination of estrogen and progesterone during preg­
nancy has been shown to inhibit milk secretion (Meites 
and Sgouris 1953)^ and lactation has been induced in pregnant 
rats by ovariectomy (Liu and Davis 196?)= 
Kuhn (1969a) has reported that progesterone administra­
tion completely inhibits both experimentally-induced and 
normal lactogenesis. At parturition there is a drop in the 
circulating progesterone levels and a shift in the estrogens 
progesterone ratio. Decline in progesterone levels at 
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parturition are probably due, in part, to increased conversion 
of this steriod to 20 a-hydroxy-4-pregnen-3-one (20 a-OH-P). 
Fajer and Barraclough (1967), Hashimoto et al. (1968), 
Wiest et al. (1968) and Labhsetwar and Watson (1974) have 
reported a drop in progesterone and an increase in serum 
20 a-OH-P levels prior to parturition in rats. Wiest and 
Forbes (1964) and Talwalker et al. (1961) have reported the 
20 a-reduced compound to have much less hormonal activity 
than progesterone,and Kuhn (1969b) has reported that this 
compound does not inhibit laetogenesis. 
Yoshinaga et al.. (1969) and Shaikh (1971) have demon­
strated an increase in estrogen prior to parturition in the 
rat. The initiation of milk secretion at term has been at­
tributed to this shift in ovarian steriods in favor of estro­
gen which stimulates prolactin release from the anterior 
pituitary (Meites and Sgouris 1954). 
Progesterone has also been shown to partially inhibit the 
stimulatory effects of estrogen on prolactin secretion in rats 
(Yokoyama et al. 1969; Chen and Meites 1970) . Liu and Davis 
(1967) and Kuhn (1969a) have demonstrated that ovariectomy or 
other means of removing progesterone from the circulation of 
mid-or late pregnant rats will induce lactation. 
It has also been demonstrated that exogenous prostag­
landin (PGFgg) induces laetogenesis and abortion in 
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pregnant rats (Deis 1971). Labhsetwar and Watson (1974) 
demonstrated, however, that the progesterone decline prior to 
parturition in the rat preceded, and was not associated with, 
the rise in PGF at parturition. 
Oxytocin and the neuroendocrine factors involved during 
parturition and suckling may also be of importance in the 
initiation and maintenance of milk secretion. Folley and 
Knaggs (1965) demonstrated the release of considerable quanti­
ties of oxytocin during parturition in the goat. Bryant, 
Greenwood and Linzell (1968) reported that the intravenous in­
jection of oxytocin to goats causes an abrupt increase in plas­
ma prolactin. Also, the suckling stimulus of the newborn 
elicits a rapid release of prolactin, adrenocorticotropic hor­
mone (ÀCTH) and oxytocin from the pituitary gland (Meites 
1959). 
The hormonal control of lactogenesis can be summarized 
in the following manner. During pregnancy, estrogen and pro­
gesterone directly inhibit the secretory activity of the 
mammary epithelium. In addition, progesterone interferes with 
the estrogen stimulated release of prolactin from the 
anterior pituitary. Biologically active corticosteriods are 
kept low during pregnancy by relatively high levels of corti-
costeriod binding globulin. At parturition the decrease in 
corticosteriod binding activity could account for an increase 
in biologically active corticoids. Also, decreased progester­
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one secretion and increased estrogen secretion are responsible 
for an important shift in the estrogen:progesterone ratio. 
Prolactin release from the anterior pituitary and removal of 
the "secretory block" on mammary epithelium could be related 
to a more favorable estrogen:progesterone ratio and to stimu­
lation by high levels of oxytocin at parturition and in 
response to suckling. 
Biochemical changes during lactogenesis 
Rivera (1974) emphasized the need for a more precise 
definition of lactogenesis than the use of appearance of 
milk in the alveoli as the end point for assessing lacto­
genesis. This is of particular importance in in vitro 
studies since the appearance of milk secretions is seldom 
evident. Biochemical markers such as casein and lactose 
serve as a more precise qualitative and quantitative assess­
ment of response. 
The^ onset of milk secretion is accompanied by an eleva­
tion in mairanary RNA (Denamur 1969, 1974) and DNA (Baldwin 1969), ^  
casein (Liu and Davis 1967), lactose (Yokoyama, et al. 1969; 
Kuhn 1968; 1971) and fatty acid synthesis (Popjak et al. 
1949; Fatton and Hood 1369). Also, the levels of several 
constituitive enzymes of the pentose cycle, glycolysis and 
citric acid cycle increase during late pregnancy (Baldwin 
and Yang 1974; Baldwin 1969). These changes reflect changes 
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in the synthetic capacity and energy requirements of the 
active secretory cell. 
Turkington et al. (1973) have suggested that cell pro­
liferation is a necessary prelude to the development of cell 
differentiation and the attainmeht of secretory function in 
cultured mammary cells. Stockdale and Topper (1966) demon­
strated that DNA synthesis (cell division) was necessary for 
the initiation of differentiation as assessed by casein 
synthesis in mouse mammary gland cultures. This would appear 
to be satisfied vivo in the rat since DNA synthesis occurs 
throughout the period of lactogenesis from late pregnancy to 
early lactation (Baldwin 1969). 
The rate of increase in enzyme activities (phosphogluco-
mutase, citrate cleavage enzyme, uridine diphosphate (UD?) 
galactose-4-epimerase and glucose-6-phosphate dehydrogenase) 
has been shown by Baldwin and Milligan (1966) to be 3- to 
4-fold per mg DNA. This illustrates an increase in the 
enzymatic capabilities of the individual secretory cells 
rather than simply an increase in enzyme activity of the 
mammary gland due to an increase in the number of cells. 
Recently Oka and Perry (1974) demonstrated that insulin, 
insulin and prolactin, and insulin, prolactin, and hydrocorti­
sone produce 100%, 200% and 250% elevations respectively in 
the activity of glueose-C-phosphate dehydrogenase activity 
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of mouse mammary epithelial cells in culture. It was also 
shown that glucose-6-phosphate dehydrogenase activity de­
clined after two days in insulin and insulin + prolactin 
stimulated cultures, but that enzyme activity was main­
tained at high levels for 4 days in the cultures containing 
hydrocortisone. 
Popjak et al. (1949) reported a 10-fold increase in the 
synthesis of short chain fatty acids from acetate at parturi­
tion in rats. These findings are consistent with an in­
crease in the respiratory quotient (R.Q.) of lactating rat 
mammary slices ^  vitro reported by Folley and French (1949). 
Gumaa et al. (1973) reported an increase in the activities of 
several mammary enzymes concerned with fatty acid synthesis 
(acetyl CoA carboxylase and fatty acid synthetase) and the 
provision of acetyl CoA units (citrate cleavage enzyme) for 
fatty acid synthesis over the period of parturition in the 
rat. Also increases in the activities of glucose-6-phosphate 
dehydrogenase and "malic" enzyme, both of which serve as a 
source of reducing agents (NADPH) for fatty acid synthesis, 
were reported over this same period. The uptake of plasma 
triglycerides at parturition is reflected in a 100=fold in­
crease in the activity of lipoprotein lipase (McBride and 
Korn 1963). 
Lactose and the lactose synthetase enzyme complex have 
been studied extensively in relation to lactogenesis and the 
15 
hormonal factors initiating milk secretion. 
Lactose synthetase is rate limiting in the synthesis of 
lactose in the mammary gland (Kuhn 1971, Baldwin and Yang 
1974). In relation to its rate limiting effects, Kuhn (1969b) 
noted only small changes in the activities of hexokinase, 
phosphoglucomutase, UDP glucose pyrophosphorylase and UDP-
glucose-4-epimerase (enzymes in the lactose pathway) but a 
15-fold increase in the acti\ity of lactose synthetase in 
mammary glands of rats during the last two days of pregnancy. 
Kuhn (1968) and Yokoyama et al. (1969) detected lactose synthe­
tase activity and lactose, respectively, in rat mammary glands 
the day before parturition. Artificial removal of progesterone 
stimulus by bilateral ovariectomy was also shown to initiate 
lactose synthesis. 
The lactose synthetase enzyme catalyzes the formation of 
lactose from UDP-galactose and glucose and is a complex enzyme 
made up of two components: the catalytic unit, galactosyl-
transferase (A-protein) and a specifier protein, a-lactalbumin 
(B protein). 
Yokoyama et al. (1969) reported that in rats lactose could 
first be detected on the 20th day of pregnancy and was fol­
lowed by an abrupt increase on the 21st day (the day before 
parturition). They were also able to demonstrate an increase 
in the lactose content of mammary glands in response to 
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ovariectomy on the 18th day of pregnancy. 
Turkington et al. (1968) demonstrated that prolactin 
stimulated the synthesis of both A and B proteins in mouse 
mammary cultures pretreated with insulin and hydrocortisone. 
They also measured the levels of these two proteins in mammary 
expiants from mice at different stages of pregnancy. The 
level of the A protein was found to increase to a maximum 
at the end of pregnancy while the B protein remained low 
throughout pregnancy, but rose dramatically at the initiation 
of lactation. They postulated that the asynchronous expression 
of A and B proteins represented a possible site for hormonal 
control of a unique biosynthetic pathway. Turkington and Hill 
(1969) extended these studies demonstrating that progesterone 
repressed a-lactalbumin synthesis. 
In contrast to studies in mouse mammary expiants, Kuhn 
(1968) noted a marked increase in galactosyl transferase co­
incident with lactogenesis in the rat. 
Molecular mechanisms 
The molecular mechanisms involved in the hormonal stimu­
lation of specific milk proteins in mouse mammary expiants have 
been the subject of intensive work by Turkington et ai. 
(1973). A characteristic sequence of hormonal stimulation 
including 1) insulin induction of stem cell division 
2) hydrocortisone stimulated differentiation of daughter cells 
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followed by 3) prolactin (and insulin) stimulation is 
necessary for the induction of the milk proteins casein and 
lactose synthetase in cultured mammary cells. 
In properly primed mammary cultures the addition of 
prolactin stimulates the appearance of all classes of RNA 
(Turkington et al. 1973) followed by the appearance of casein 
and both A and B proteins of lactose synthetase. Thus, the 
induction of specific milk proteins by prolactin is preceded 
by the activation of transcription of multiple classes of 
RNA. 
Gene activation and transcription are probably regulated 
by DNA-associate histone and non-histone acidic protein (HHP) 
(Monahan and Hall 1974). Studies of mammary epithelial cell 
histones have demonstrated that these proteins lack the 
specificity for regulating the transcription of the vast number 
of genes on a DNA molecule. The non-histone acidic proteins 
(NHP), in contrast to the histones, are highly species-and 
tissue-specific (Gilmour and Paul 1969; Kleinsmith et al. 1970). 
Turkington et al. (1973) have reported differences in the 
electrophoretic patterns of NHP isolated from mammary glands 
of virgin and lactating mice and that DNA and NKP synthesis 
in mammary expiants is stimulated by insulin, but not hydro­
cortisone and/or prolactin. Therefore, accumulation of these 
proteins is stimulated by factors affecting cell proliferation. 
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but not by the hormones which stimulate milk protein synthesis 
in differentiated alveolar cells in culture. These results 
emphasize the role of mitosis in mammary cell differentiation 
and Turkington (1971) has demonstrated that DNA replication and 
cell division are required for the derepression of the genes 
for milk protein synthesis ^  vitro. 
Turkington and Riddle (1969) have demonstrated the in-
32 
corporation of P from ATP into histones and non-histone 
nuclear protein and that phosphorylation of these nuclear pro­
teins was temporally associated with activation of transcrip­
tion by insulin and prolactin. Subsequently, Turkington and 
Riddle (1970) and Kadohama and Turkington (1973) have demon­
strated that the nuclear proteins phosphorylated are primarily 
the ^2^3 ^2" histones and all species of acidic nuclear 
proteins. 
Majumder and Turkington (1971a) isolated two protein 
kinases (I and II) in cytosol of mammary cells which demon­
strated a high degree of specificity for histones. The 
activity of protein kinase II was markedly stimulated by 
cyclic AMP. It was reported that cyclic AMP interacts 
with protein kinase II causing the release of a cyclic AMP-
binding subunit and the active catalytic subunit protein 
kinase I. 
Protein kinase and cyclic AMP-binding protein activities have 
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been demonstrated to increase approximately 7- to 9-fold from 
virgin animals to day 20 of pregnancy followed by an un­
explained precipitous drop at the time of parturition 
(Majumder and Turkington 1971a). In addition, these same 
workers reported that the cyclic AMP-dependent protein kinase 
could be induced in insulin-stimulated mitotic cells solely 
by prolactin. Furthermore, neither prolactin nor insulin 
stimulated adenylate cyclase activity in isolated mammary 
cell membrane. 
It was proposed that the possible mechanism for regu­
lation (of phosphorylation of nuclear proteins) was controlled 
by the rate of synthesis of a cyclic AMP-dependent enzyme rather 
than the level of the cyclic nucleotide. 
Cyclic Nucleotides and Hormone Action 
Cyclic nucleotides apparently regulate many different 
physiological phenomena and have been implicated as inter­
mediates in hormonal stimulation (Sutherland 1972; Robison^,, 
et al. 1971; Goldberg et al. 1973b; Major and Kilpatrick 1972; 
Harâman 1974). 
The concentration of cyclic adenosine 3'-5'-monophosphate 
(cyclic AMP) and cyclic guanosine 3',5'-monophosphate (cyclic 
GMP) represent only a small fraction of the total adenine or 
guanine nucleotide content of tissue. Cyclic AMP concentra­
tions are reported to be in the range of 0.1-1.0 y mol/kg wet 
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tissue (Hardman 1974) and cyclic GMP concentrations are 
usually 1/10 to 1/100 the levels of cyclic AMP (Goldberg et al. 
1973a). 
Cyclic AMP is synthesized from adenosine triphosphate 
(ATP) by membrane bound adenylate cyclase (AC). Magnesium 
(Mg^^) or manganese (Mn^^) is required for enzyme activity 
(Hardman 1974). Degradation of the cyclic nucleotide is 
controlled by hydrolysis of the 3'bond by a phosphodiesterase 
to form 5'-adenosine monophosphate (5'-AMP). 
Cyclic GMP is synthesized from guanosine triphosphate 
(GTP) by the enzyme guanylate cyclase (GC) . The reaction 
appears to be analogous to the formation of cyclic AMP from 
adenosine triphosphate (ATP), however, several differences 
have been found with respect to subcellular distribution 
and substrate and cation requirements (Goldberg et al. 1973a). 
Unlike adenylate cyclase, which has been reported to 
occur predominantly in the plasma membrane fractions of tissue 
homogenates (Perkins 1973), the major portion of guanylate 
cyclase appears to reside in the soluble fraction after 
homogenization of most tissues (White and Aurbach 1969; 
Hardman and Sutherland 1969), The exact location is, how­
ever, less certain than the location of adenylate cyclase 
since, even in tissue homogenates where the majority of GC 
activity appears to be cytoplasmic.- there is significant 
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(10-20%) activity associated with the membrane fraction. 
Also, in some tissues (i.e. small intestine) the majority 
of activity is found in the particulate fraction, whereas, 
other tissues (i.e. heart) have intermediate distribution 
between cytoplasm and membrane fractions (Goldberg et al. 
1973a). One interpretation might be that the intracellular 
distribution of guanylate cyclase is different in different 
tissues; another explanation is that possibly the guanylate 
cyclase becomes dissociated to a greater or lesser extent 
during the homogenization procedure. Goldberg et al. (1973a) 
feel: that the cytoplasmic location of guanylate cyclase in 
certain tissues may be more apparent than real and may be due 
to the fractionation procedures of in vitro experiments. 
The requirement of guanylate cyclase activity for Mn^^ 
is another property which appears to distinguish it from 
++ 
adenylate cyclase which can apparently utilize either Mg or 
I* j 
Mn equally well. The guanosine triphosphate (GTP) to Mn 
ratio may be an important factor in controlling guanylate 
cyclase activity, since Hardman and Sutherland (1969) demon­
strated that increasing GTP concentrations in the presence of 
fixed,- low concentrations of inhibited enzyme activity. 
Another interesting difference between the two cyclases 
is the effect of calcium (Ca^^^ on the activity of the enzymes. 
In most cases, the activity of adenylate cyclase is inhibited 
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by the presence of Ca**. Blrnbaumer et al. (1970) reported 
that hormonal stimulation of adenylate cyclase from fat cell 
ghosts is enhanced in the presence of a calciim chelator 
(E6TA) with the one exception: that stimulation by ACTH 
was markedly inhibited by EGTA. In contrast Ca^* seems 
to stimulate guanylate cyclase activity. Hardman et al. (1972) 
have demonstrated that Ca could enhance guanylate cyclase 
activity several fold when present with Mn^^ and adequate 6TP. 
These findings suggest that the ion composition of the cells 
is an important factor in the regulation of the activity of 
the cyclases. 
Cyclic GMP is degraded in the cell by phosphodiesterase 
hydrolysis of the 3' bond to form 5'-GMP similar to the de­
gradation of cyclic AMP. Early investigation (Drummond and 
Perrott-Yee 1961) seemed to indicate the presence of a 
common phosphodiesterase, but more recent studies seem to 
indicate the presence of specific phosphodiesterase enzymes 
(Thompson and Appleman 1971; Kakiuchi et al. 1971). 
The second messenger hypothesis 
Sutherland, 0ye and Butcher (1965) introduced the second 
messenger theory to explain the actions of a variety of amine 
and polypeptide hormones. In this model the "first messenger" 
or hormone interacts with its specific receptor on the cell 
membrane which closely associated with the membrane bound 
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cyclase (adenylate cyclase). As a result of hormone-receptor 
interaction adenylate cyclase activity is either stimulated or 
suppressed with the respective increase or decrease in the 
"second messenter", cyclic AMP. According to this concept 
the first messenger (hormone) carries the information to the 
cell and the second messenger (cyclic AMP) transfers the in­
formation internally to obtain the appropriate intracellular 
response. 
Cyclic AMP is thought to act by activating protein 
kinases (Walsh st al. 1968), which subsequently phosphorylate 
a number of diverse proteins within the cell. Langan (1973) 
has reviewed the role of protein kinases and has made the 
following conclusions: 1) that protein kinases seem to be 
involved in each of the well documented cases of cyclic AMP 
action and 2) that one cyclic AMP protein kinase, in spite 
of existing in multiple forms, is capable of mediating a 
variety of hormone actions. 
It is therefore probable that the response of a particu­
lar cell to a rise in cyclic AMP is essentially determined by 
the number and types of protein kinase substrates present. 
The substrates are in turn regulated by the genetic expression 
in the cell. 
There is evidence for the presence of cyclic GMP-dependent 
protein kinase in several systems although the substrate 
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specificities for this kinase are less clear than those for the 
cylic AMP-dependent kinase (Goldberg et al. 1973a). Before the 
natural concentration of cyclic GMP was known, Rail and Suther­
land (1962) demonstrated that cyclic GMP was 1/500 as potent as 
cyclic AMP in activating dog liver glycogen phosphorylase. 
Schlender et al. (1969) demonstrated that, while both 
cyclic AMP and cyclic GMP were capable of stimulating rabbit 
muscle glycogen synthetase-I kinase (cyclic AMP-dependent 
protein kinase), the association constant (K^) for the two 
cyclic nucleotides were 0.07 and 9»9 mM,respectively, Majumder 
and Turkington (1971b) reported that interference with cyclic 
AMP binding to mouse mammary gland protein kinase by cyclic GMP 
occurs only at relatively high concentrations of the latter. 
Recently, however, Goldberg et al. (1973a) demonstrated a 20-30% 
inhibition of cyclic AMP binding to skeletal muscle protein 
kinase by 10 to 10 M cyclic GMP. This appears to be a 
significant amount of inhibition with cyclic GMP close to the 
physiological range. 
Kuo and Greengard (1969, 1970a) were the first to report 
the occurrence of a protein kinase which seemed to be more 
sensitive to cyclic GMP than to cyclic AMP stimulation. Pro­
tein kinases were purified from lobster tail muscle showing 
specificity for cyclic AMP and cyclic GMP. The protein kinase 
more sensitive to activation by cyclic GMP (cyclic GMP= 
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dependent protein kinase) exhibited of 0.08 uM for cyclic 
GMP and a value 50-fold higher for cyclic AMP. Interesting­
ly, a protein factor isolated by Appleman et al. (1966) from 
mammalian and arthropod tissue and believed to be similar 
to the protein inhibitory subunit of cyclic AMP-dependent 
protein kinase, was found by Kuo and Greengard (1971) to 
stimulate cyclic GMP dependent protein kinase from lobster 
muscle. 
It is not, as yet, clear what the substrate or substrates 
are for the cyclic GMP-dependent protein kinase, but Kuo and 
Greengard (1970b) have compared the effects of cyclic AMP-
and cyclic GMP-dependent protein kinases on the phosphoryla­
tion of histones. Although they found that both cyclic AMP 
and cyclic GMP were able to utilize histones as substrate-
there were marked differences in the phosphorylation patterns 
catalyzed by the cyclic nucleotide-dependent protein kinases. 
They concluded that there were probably separate and inde­
pendent roles for cyclic AMP and cyclic GMP and their re­
spective protein kinases. 
Recently, Johnson and Madden (1975) have reported that 
cyclic GMP stimulates the incorporation of phosphate into 
specific nuclear acidic proteins of horse peripheral blood 
lymphocytes. Furthermore they determined that prostaglandin 
(PGE^, which elevates cyclic AMP in lymphocytes) inhibited 
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the phosphorylation of acidic non-histone nuclear proteins. 
The role of guanosine 5•-triphosphate (GTP) as a possible 
activator of the adenylate cyclase was investigated by Leray 
et al. (1972). Assay of adenylate cyclase activity in rat 
liver plasma membranes revealed that GTP was capable of en­
hancing the response of the enzyme to stimulation by both 
glucagon and epinephrine. Siegel and Cuatrecasas (1974) 
studied the effect of Mg and GTP on the regulation of fat 
cell adenylate cyclase. They found that in the presence of 
4*4* 
Mg , GTP is no longer required but that it enhances the 
response to epinephrine. GTP was found to lower the appa­
rent affinity of adenylate cyclase for ATP, while simultaneous­
ly increasing the velocity of the catalytic reaction. It was 
postulated that hormonal responsiveness is controlled by 
varying substrate (ATP, GTP and Mg"^"^) concentrations. 
Dualism theory 
The "dualism theory" was proposed by Goldberg et al. 
(1973a,b) to explain the reciprocal relationship between 
cyclic AMP and cyclic GMP that had been reported by several 
investigators. According to this theory, cyclic GMP produces 
a cellular response opposite to or antagonistic to those that 
occur when the concentration of cyclic AMP is elevated. 
George et al. (1970) reported that acetylcholine (Ach) 
perfused rat hearts produced an elevation of myocardial cyclic 
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GMP coincident with the first signs of cholinergically-induced 
depression of cardiac function. They found that cyclic GMP 
levels were elevated 280% 10 sec after Ach administration, 
then leveled at 150% above control values, 30 sec after ad­
ministration. Cyclic AMP was reported 40% lower, 20 sec 
after cholinergic treatment and returned to control levels by 
30 seconds. Pretreatment of the hearts with atropine, a 
muscarinic blocking agent, prevented depression of cardiac 
function and elevation of cyclic GMP in response to Ach. Iso­
proterenol, a strong adrenergic agent depressed cyclic GMP, 
stimulated cyclic AMP accumulation and increased rate and 
force of contraction. 
Kuo and Kuo (1973) reported that isoproterenol increased 
pulmonary cyclic AMP levels 3-fold, while Ach elevated cyclic 
GMP levels 3-fold. The effects of isoproterenol or acetyl­
choline were blocked by propranolol or atropine, respectively. 
Oxytocin and serotonin have been reported to elevate 
cyclic GMP levels in uterine smooth muscle with no signifi­
cant effect on cyclic AMP (Goldberg et ai. 1973b). This is 
reported to be the first demonstration of an increase in 
tissue cyclic GMP associated with a peptide hormone and by a 
neurohormone other than Ach. 
Stone et al. (1975) reported opposing effects of cyclic 
AMP and cyclic GMP on electrophysiologically identified pyra­
midal tract neurons. Norepinephrine and cyclic AMP inhibited 
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the firing of these neurons while cyclic GMP and Ach excited 
the neurons. It was suggested that these two cyclic nucleo­
tides possibly function as reciprocal intracellular second 
messengers for norepinephrine and Ach, respectively. 
In contrast to most reports which have associated cyclic 
GMP with muscarinic cholinergic stimulation and cyclic AMP 
with adrenergic stimulation, Ferrendelli et al. (1975) re­
ported that norepinephrine (NE) elevates levels of both cyclic 
AMP and cyclic GMP in incubated mouse cerebellar tissue. 
Omission of Ca^^ from the incubation medium blocks the NE 
stimulated accumulation of cyclic GMP but not cyclic AMP. 
The role of Ca agrees well with previously cited reports 
(Birnbaumer et al. 1970; and Hardman et al. 1972) which 
4* "h demonstrated that Ca was a stimulator of guanylate cyclase 
and an inhibitor of adenylate cyclase. 
Goldberg et al. (1974) demonstrated a reciprocal rela­
tionship between cyclic nucleotides in bovine vein prepara­
tions. They noted that prostaglandin (PGFgg) caused 
contraction and an increase in the cyclic GMP to cyclic AM? 
ratio. Conversely, prostaglandin E, stimulated relaxation and 
a decrease in the cyclic GMP to cyclic AMP ratio. 
Elevation of intracellular cyclic AMP inhibits cell pro­
liferation in many systems (Abell and Monahan 1973) . Otten 
et al. (1971) have demonstrated that the intracellular level 
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of cyclic AMP was inversely related to the rate of DNA syn­
thesis in 13 separate cell lines. Furthermore, they found 
that in 3T3 cells transformed by simian virus 40 (SV40) there 
was a corresponding decrease in cyclic AMP levels associated 
with uncontrolled cell proliferation. Sheppard (1972) con­
firmed and extended these findings by demonstrating that 
prostaglandin E^tPGE^) increased intracellular cyclic AMP 
levels and inhibited growth in transformed 3T3 cells. Bannai 
and Sheppard (1974) have also reported an increase in cyclic 
AMP levels of cultured 3T3 cells during normal contact in­
hibition. 
Hadden et al. (1972) reported that phytohemaglutinin 
(PHA) and concanavalin A stimulated proliferation of human 
blood lymphocytes, produced a 10- to 50-fold increase in cellu­
lar cyclic GMP concentrations and had no effect on cyclic AMP 
synthesis. 
Voorhees et al. (1973) investigated cyclic nucleotide 
levels in the rapidly proliferating epithelium of psoriosis. 
They found that gyclic AMP levels were relatively low and 
cyclic GMP levels relatively high in rapidly proliferating 
psoriatic lesions when compared with uninvolved epithelium. 
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Cyclic Nucleotides in Mammary Tissue 
Other than the reports of Turkington and co-workers 
(Turkington et al. 1973) on the role of cyclic AMP-dependent 
protein kinases in mouse mammary cultures, there exists few 
reported studies of the occurrence or role of cyclic nucleo­
tides in normal mammary tissue. 
Bar (1973) has reported an epinephrine- and prostalgan-
din-sensitive adenylate cyclase in rat and rabbit lactating 
mammary gland tissue. The enzyme activity from rat lactating 
mammary tissue was found to be low, i.e. below 2-3 p mbl/mg/ 
min in unstimulated tissue. Sodium fluoride (NaP) was observed 
to stimulate cyclase activity 2- to 4-fold. Epinephrine stim­
ulation was observed only after collagenase digestion of 
tissues and then only to a relatively small but highly sig­
nificant 70-80%. Oxytocin, vasopressin, glucagon, ACTH, 
thyrotropic hormone and PGE^ had no effect on enzyme activity^ 
The adenylate cyclase from rabbit mammary gland was responsive 
to prostaglandins ^ and in addition to epinephrine. 
Oxytocin, vassopressin, ACTH, thyrotropic hormone, glucagon, 
parathyroid hormone and prolactin had no effect on enzyme 
activityc 
Sapag-Hagar and Greenbaum (1973) reported changes in 
adenylate cyclase and phosphodiesterase activities and in 
cyclic AMP levels of the rat mammary gland at various stages 
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of pregnancy and lactation. Cyclic AMP levels were found to 
increase during pregnancy to peak levels on day 20 of ap­
proximately 680 p mol/g on day 1 of lactation and continued 
to decline throughout lactation to approximately 200 p mol/g 
on day 16 of lactation. Adenylate cyclase activity was ob­
served to parallel the changes in cyclic AMP# while phospho­
diesterase rose during pregnancy and continued to rise through­
out lactation. In an attempt to more clearly define the 
role of cyclic AMP in the mammary gland, Sapag-Hagar et al. 
(1974) subsequently investigated the activities of several 
enzymes from 10-day or 20-day pregnant rat mammary tissue. 
Expiants were incubated in the presence or absence of di-
butyrl cyclic AMP. Virtually every enzyme studied (including 
glucose-6-phosphate dehydrogenase, citrate cleavage enzyme and 
fatty acid synthetase) was depressed by the presence of cyclic 
AMP in the incubation medium. Cyclic AMP also was noted to 
inhibit the incorporation of radioactive precursors into 
RNA, DNA and fatty acids. 
32 
METHODS 
Treatment of Animals 
Virgin, female rats of the Sprague-Dawley strain, 
weighing iaO-200 grams, obtained from Sasco, Omaha, Nebraska, 
were maintained on a commercial lab chow (Wayne) and water 
ad libitum. Light (8 a.m. to 10 p.m.) and temperature (25C) 
were controlled. 
Six female rats were placed in breeding cages with one 
male. Vaginal smears of each rat were made in the morning, 
and the presence of sperm was considered as evidence of day 
one of pregnancy. Pregnant rats were transferred to 
smaller cages, one or two rats per cage and sacrificed on 
either day 14 (P14) or 20 (P20) of pregnancy or day 1 (LOI) 
or 3 (L03) of lactation (the day of parturition being desig­
nated day 1 lactation). 
Tissue Preparation 
On the day of sacrifice the total body weight of each 
animal was recorded. Small portions of mammary tissue from 
the inguinal region of the animal were rapidly excised and 
frozen in liquid nitrogen while the animal was under light 
ether anesthesia. This tissue was used for analysis of cyclic 
nucleotides. The rat was then sacrificed by decapitation. 
The three remaining abdominal inguinal mammary glands were 
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excised in toto, weighed wet and transferred to chloroform: 
methanol for defatting as described in Appendix A. This 
tissue was used for nucleic acid analysis. Corrected body 
weights were calculated for each animal by subtracting the 
total uterine weight from total body weight. 
Nucleic Acid Determinations 
RNA and DNA were extracted from 25 mg samples of dried 
fat-free tissue (DFFT) in hot trichloroacetic acid (TCA) ac-
cording to the method outlined by Schneider (1945) and modi­
fied by Ferreri (1971). 
DNA and RNA content of the mammary glands were then both 
estimated by colorimetric procedures. DNA content was esti­
mated by the diphenylamine method of Burton (1956). RNA 
content was estimated by the orcinol procedure of Mejbaum 
(1939)j as described by Schneider (1957). 
The absorbance measured in the mammary gland extracts 
was compared to the absorbance measured in standards of known 
nucleic acid concentration. The standard solutions of hydro-
lyzed DNA and RNA were prepared according to the method out= 
lined by Webb and Levy (1955). The accuracy of the standards 
was established by colorimetrically determining the phosphorus 
content according to the method of Fiske and Subbarow (1925). 
All colorimetric determinations were made on a Beckman 
Model 24 Spectrophotometer. Tissues were extracted in dupli-
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cate and each extract was assayed in duplicate for both RNA 
and DNA. The mean of four determinations was then calculated 
for each Scunple. Details of the extraction procedure and the 
colorimetric determinations of nucleic acids are outlined in 
Appendix A. 
Cyclic Nucleotide Analysis 
Both cyclic AMP and cyclic GMP were analyzed using com­
mercially available radioimmunoassay kits (Schwarz/Mann, 
Orangeburg, N.Y.). The radioimmunoassay of cyclic nucleo­
tides has been described by Steiner, Parker and Kipnis (1972) 
and Steiner et al. (1972). The protocol upon which the 
cyclic AMP and cyclic GMP radioimmunoassay kits are based 
follows procedures described by Steiner et al. (1972). 
The preparation of tissue samples and the complete protocol 
are outlined in Appendix B. 
For both assays, two extracts of each tissue sample were 
assayed in triplicate. The mean of six observations was 
calculated for each sample. 
Effect of Oxytocin on Cyclic GMP Levels 
Because oxytocin administration has been shown to ele­
vate cGMP levels in the uterus (Goldberg et al. 1973b) a 
preliminary experiment was performed to test the effect of 
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exogenous oxytocin on the levels of cyclic GMP in the mammary 
gland. 
Five, 10-day lactating rats that were nursing at least 
6 pups were isolated from their litters for 10 hours. The 
dams were then anesthetized with sodium pentobarbitol (50 
mg/kg body weight) thereby blocking the neuroendocrine re­
lease of oxytocin from the posterior pituitary in response 
to the suckling stimulus. A median incision was made in 
the skin above the abdominal mammary glands. The mammary 
glands were carefully dissected from the skin leaving teat 
connections intact. Six pups were transferred to the dam 
and allowed to suckle. A piece of mammary tissue (approxi­
mately 100 mg) was dissected from the dam after the pups had 
been allowed to suckle for 2 minutes and prior to the oxyto­
cin injection. This sample was considered the control 
sample or 0 (zero) time samples,- Oxytocin (2 u.s.P. units) 
was then injected intraperitoneally and mammary tissue 
samples (approximately 100 mg) were collected at 30, 90 and 
300 seconds postinjection, frozen in liquid nitrogen and 




Data are presented, for convenience, in two sections: 
(1) nucleic acid analysis and (2) cyclic nucleotide analysis. 
Nucleic Acid Analysis 
Data for body weights, dried fat-free tissue (DFFT), 
total DNA, total RNA, DNA/lOOg body weight (index of cellu­
lar ity) and RNA:DNA ratio (index of metabolic activity) are 
presented in Table 1 and Figures 1 and 2. Significance levels 
(Student's t-test) are presented in Figure 3 for comparison 
between groups. 
No significant differences in body weights were noted. 
Maxranary gland DFFT increased significantly (P<0.01) from 223.8 
mg on day 14 of pregnancy to 283.5 mg on day 20 of pregnancy. 
A further significant increase was noted from the 20th day 
of pregnancy to the 1st day of lactation (465.6 mg DFFT; 
P<0.001). There was no significant difference in DFFT be­
tween day 1 and day 3 (457.5 mg) of lactation. 
The DNA levels of the mammary gland paralleled the 
changes in DFFT content of the gland as can be seen in 
Figure 1. There was a significant (p<0,005) increase in 
total mg DNA/100 g body weight from day 14 (3.09) to day 20 
(3.80) of pregnancy, followed by a significant (P<0.005) in-
















P14 10 283 223. 8+11. 8*^ 8. 69+0. 43 11. 60+0. 66 3. 09+0. 16 1. 33+0. 03 
P20 10 294 283. 5+18. 0 11. 17+0. 44 18. 01+1, JL5 3. 80+0. 13 1. 60+0. 07 
LOI 10 273 465. 6+15. 4 12. 35+0. 51 31. 03+1. 29 4. 54+0. 16 2. 52+0. 05 
L03 10 290 457. 5+19. 2 13. 22+0. 52 33. 77+1. 86 4. 53+0. 10 2. 55+0. 10 
^Corrected for total uterine weight. 
^Dry fat-free tissue. 
^For three abdominal-inguinal mammary glands. 









































Figure 1. Total mg DFFT and total mg DNA/100 
rats at days 14 ànd 20 of pregnancy 
lactation (LOI; L03) 
g body weight in mammary glands of 








Z  on 
PiU P E G  I  01  1 0 3  
Figure 2. Rat mammary gland RNA:DNA ratios during pregnancy 
(P14; P20) and lactation (LOI; L03) 
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T O T A L  M G  D N A / l O O  G  B W  
P20 0.005 
LOI 0.001 0.005 
L03 0.001 0.001 N.S. 
P I 4  P 2 0  L O I  
DFFT 
P20 0.01 
LOI 0.00! 0.00! 
L03 0.001 0.001 N.S. 
PI4 P20 LOI 
R N A : D N A  R A T I O  
P 2 0 |  0 . 0 0 5  1  
L O I  I  0 . 0 0 1  I  0 . 0 0 1  I  
I I L O S j  0 . 0 0 1  { 0 . 0 0 1  }  N . S .  i  
P I 4  P 2 0  L O I  
Figure 3. Significance levels (Student's t-test) between all 
groups for nucleic acid analysis 
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crease from day 20 to day 1 of lactation (4.54). No sig­
nificant change was noted between day 1 and day 3 (4.53) of 
lactation. 
The RNA:DNA ratio increased throughout pregnancy (P14= 
1.33; P20=1.60) to the 1st day of lactation (2.52), with no 
change between the 1st and 3rd day of lactation (2.55). The 
significance levels between day 14 and day 20 of pregnancy 
and between day 20 of pregnancy and the first day of lacta­
tion were P<0.005 and P<0.001 respectively. 
Cyclic Nucleotide Analysis 
Differences in the number of rats per group in cyclic 
nucleotide analysis from the number of rats per group in 
nucleic acid analysis are accounted for by the discard of 2 
outliers (lying >3 standard deviations from the mean) in 
group P20 and the presence of missing values in one rat from 
each of the other three groups. 
The mean coefficient of variation (CV) between duplicate 
samples in the cyclic AMP assay was 54.35+27.47%, while the 
mean CV within samples was 5.64+1.31%. For the cyclic GMP 
assay the mean CV between duplicate samples was 23.95+4.27% 
and the within sample CV was 4.37+1.02%. 
Data for p mol cyclic nucleotide per g wet mammary tissue 
as calculated directly from the assay are presented, along with 
values for total cyclic nucleotides in the mammary gland, in 
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Table 2. Graphie representation of the changes in cyclic 
nucleotides per g wet tissue over the assay period is in 
Figure 4. Significance data are in Figure 8. 
A significant (P<0.001 from P14; P<0.025 from LOI) peak 
in the concentration of cyclic AMP (390.5 p mol/g wet tissue) 
was noted on the 20th day of pregnancy. Values for p mol 
cAMP/g wet tissue for day 14 of pregnancy and days 1 and 3 of 
lactation were 143.33, 250.78 and 217.11, respectively. Days 
14 of pregnancy and 3 of lactation were not significantly dif­
ferent, but day 1 of lactation was significantly different 
(P<0.025) than day 14 of pregnancy. Values for p mol cyclic 
GMP/g wet tissue were 5.36, 5.70, 7.97 and 8.07 for days 14 
and 20 of pregnancy and days 1 and 3 of lactation, re­
spectively. A significant (P<0.05) increase was noted between 
days 20 of pregnancy and 1 of lactation. 
Similar results were obtained when the cyclic nucleotides 
were expressed per mg DNA (Table 3, Figures 5 and 8). A 
significant increase in p mol cyclic AMP/mg DNA was noted 
between days 14 (52.94) and 20 (132.31) of pregnancy. There 
was a decline in levels from day 20 of pregnancy to day 1 of 
lactation (100.53) which was not significant and a decline 
from day 1 to day 3 (81.39) which was not significant. The 
overall decrease in p mol cyclic AMP/mg DNA from day 20 of 
pregnancy to day 3 of lactation was, however, significant 
(P<0.05) Picomoles cyclic GMP/mg DNA were statistically the same 
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on days 14 (1.98) and 20 (1.88) of pregnancy. There was a 
significant increase between day 20 of pregnancy and day 1 
of lactation (3.25 p mol cyclic GMP/mg DNA). The difference 
between the mean p mol cyclic GMP/mg DNA on day 1 of lactation 
and day 3 of lactation (2.84) was not significant. 
Cyclic nucleotide data expressed as a percentage of day 
14 pregnancy levels are shown in Table 4 and Figure 6. A 
profound increase in cyclic AMP levels was noted on day 20 
of pregnancy followed by declines on both days 1 and 3 of 
lactation. In contrast, cyclic GMP levels were unchanged when 
compared with day 14 levels and were elevated 50% during the 
two days of lactation measured. 
When the data were expressed as a ratio of cyclic AMP to 
cyclic GMP, there was a noted a significant (P<0=005) in­
crease on day 20 (71.89) when compared with day 14 of preg­
nancy (30.38), day 1 of lactation (33.83) and day 3 of 
lactation (29.87). (See Table 5 and Figures 7 and 8). 
Effect of Oxytocin 
No significant changes in mammary gland cyclic GMP levels 
were noted following injection of oxytocin into anesthetized 
lactating rats (Table 6; Figure 9)= Mean values for p mol 
cyclic GMP per g wet mammary tissue were 23.02, 19,14, 17,52 
and 17.60 for controls and 30, 90 and 300 second post in­
jection, respectively. 
Table 2. Mamraciry gland cyclic nucleotide content 
No. ïîWT^ cAîIP . cGMP V Total cAMP Total cGMP 
of (g) (p mol/gn (P mol/g ) (p mol) (p mol) 
rats 
P14 9 3. 12+0. 19° 143. 33+19. 14 5. 36+0. 55 451. 89+72.23 16. 64+1. 74 
P20 8 3. 70+0. 34 390. 50+35. 04 5. 70+0. 52 1490. 34+238.96 20. 89+2. 41 
LOI 9 5. 15+0. 13 250. 78+37. 13 7. 97+0. 85 1275. 64+189.53 41. 30+4. 88 





^Total tissue wet weight of 3 abdominal-inguinal mammary glands. 
^Picomoles/gm wet tissue. 
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Figure 4. Picomoles of cyclic nucleotide per gram of wet 
mammary tissue 
Table 3. Mammary gland cyclic nucleotide^content per milligram DNA 
Total CAMP Total cGMP Total DNA cAMP/DNA cGMP/DNA 
(p mol) (p mol) (p mol) (p mol/mg) (p mol/mg) 
P14 451. 89+72.23* 16. 64+1. 74 8. 47+0. 41 
CM in 
94+7. 23 1. 98+0. 20 
P20 1490. 34+238.96 20. 89+2. 41 11. 13+0. 53 132, 21+19 .14 1. 88+0. 20 
LOI 1275. 64+189.53 41. 30+4. «8 12. 61+0. 48 100. 53+13 .56 3. 25+0. 33 
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Figure 5. Picomoles (pm) of cyclic nucleotide per 
milligram (mg) DNA 
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cAMP cGMP cAMP cGMP 
100.00 100.00 100.00 100.00 
272.45 106.14 249.73 95.43 
174.97 148.42 189.89 164.97 





^Picomoles cyclic nucleotide/g wet tissue. 
^Picomoles cyclic nucleotide/mg DNA. 
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Figure 6» Percent change of cyclic nucleotides when com­
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Figure 7. Cyclic AMP;cyclic GMP ratio 
L05 
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PM CAMP/G WET TISSUE PM CGMP/M6 WET TISSUE 
P20 0.001 P20 N.S. 
LOI 0.025 0.025 LOI 0.025 0.05 
L03 N.S. 0.005 N.S. L03 0.025 0.05 N.S. 
P I 4  P20 L O I  P I 4  P20 LOI 
CAMP/C6MP RATIO 
P20 0.001 
LOI N.S. 0.005 
LOS N.S. 1 0.005 N.S. 1 
P I 4  P20 LOI 
PM CAMP/MG DNA PM CGMP/MG DNA 
I Z I 
P20| 0.005 I 
Lw 0! I 0.005 I N.S. I 
L03 N.S. 0.05 N.S. 
P I 4  P20 LOI 
P2o|^N.S. 
. 1 
LOI i  0.005 i  0.005 ! 
LOs! 0.01 1 0.01 N.S. 
PI4 P20 LOI 
Figure 8. Significance levels (Student's t-test) between 
groups for cyclic nucleotide analysis 
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Table 6. Effect of exogenous oxytocin of mammary gland cyclic 







^picomoles/mg wet tissue. 
^Mean + S.E.M. 
®Time elapsed after oxytocin injection 
23.02 + 4.47° 
19.14 + 3.61 
17.52 + 2,47 
17.60 + 2.72 
O X Y T O C I N  
•o MEAN 
SECONDS 
Figure 9. Effect of exogenous oxytocin of mammary gland cyclic 
GMP levels of lactating rats 
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DISCUSSION 
Changes in rat mammary gland cyclic AMP levels during 
pregnancy and lactation have been reported by Sapag-Hagar and 
Greenbaum (1973). Increasing levels during pregnancy, a 
precipitous drop around the time of parturition, and de­
creasing levels during lactation suggest that cyclic AMP may 
be important in suppressing events associated with lacto-
genesis and lactation. 
Recent studies (Goldberg et al. 1973a,b) suggest that 
cyclic GMP may be important in controlling cellular events 
antagonistic to those mediated by cyclic AMP. This investi­
gation was designed to explore the relationship between these 
two cyclic nucleotides in the rat mammary gland around the 
time of parturition and lactogenesis. 
The results demonstrate a distinct change in the ratio 
of cyclic AÎ'!? to cyclic GM? on day 20 of pregnancy which im­
mediately precedes by one day the reported increase in lactose 
content (Yokoyama et al. 1969) and lactose synthetase activity 
(Kuhn 1968)-in rat mammary glands. It seems reasonable to think 
that this shift in the cyclic nucleotide ratio might have a 
relationship to the onset of lactogenesis. The changes in 
cyclic AMP levels from day 14 of pregnancy to day 3 of lac­
tation follow very closely the pattern reported by Sapag-Hagar 
and Greenbaum (1973) although the levels reported here were 
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found to be consistently lower. Furthermore the decrease in 
cyclic AMP levels noted between day 20 of pregnancy and day 1 
of lactation occurs over the same time period that Majumder and 
Turkington (1971b) reported a drop in cyclic AMP-dependent 
protein kinase activity ^  vivo in mouse mammary glands. 
The increase in cyclic GMP levels noted between day 20 of 
pregnancy and day 1 of lactation may be an antagonistic event, 
opposed to or contributing to the decrease in cyclic AMP 
levels over this same time period. 
Neither prolactin (Majumder and Turkington 1971b) nor 
glucocorticoids (Thompson and Lippman 1974), both of which 
are necessary for lactogenesis and lactation, are known to 
have any direct effect on cyclic nucleotide metabolism. 
Cyclic AMP does, however, seem to be involved in the activa­
tion of a protein kinase from mouse mammary gland which pre­
cedes prolactin-induced phosphorylation of specific nuclear 
proteins (Majumder and Turkington 1971b). Prolactin has 
also been shown to induce the synthesis of both A and B 
proteins of lactose synthetase. The B protein (a-lactalbumin) 
remains at low levels until the onset of lactation. Possibly# 
the increase in cyclic AMP and cyclic AMP-dependent protein 
kinase are involved in the differentiation of mammary epi­
thelial cells and the induction of a-lactalbumin directly 
before the onset of milk secretion. After differentiation, 
cyclic AMP and cyclic AMP-dependent protein kinase may no 
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longer be necessary for the function of the lactational cell. 
(In fact, it has been shown that cyclic AMP inhibits the ac­
tivity of several metabolic enzymes in the rat mammary gland 
(Sapag-Hagar et al. 1974), including fatty acid synthetase 
which has been shown to be elevated during lactation.) 
The finding that cyclic AMP inhibits fatty acid synthesis 
is supported by Bricker and Levey (1972) who reported a sig­
nificant inhibition of fatty acid and cholesterol synthesis 
in rat liver slices by cyclic AMP (5 x 10*"^ M) , although this 
study and the study by Sapag-Hagar et al. (1974) using 10~^M 
dibutyryl cyclic AMP employed the cyclic nucleotide in extreme 
excess of physiological concentrations. In addition, Allred 
and Roehrig (1973) demonstrated that cyclic AMP inhibits acetyl 
CoA carboxylase activity in rat liver, the report by Carlson 
and Kim (1973) that partially purified acetyl CoA carboxylase 
can be inactivated by a phosphorylation reaction in the presence 
of ATP, Mg^^, and a protein fraction ("Fraction K") suggests a 
possible control point for a cyclic AMP-dependent kinase. Al­
though cyclic AMP was reported to have no effect on enzyme ac­
tivity, a cyclic AMP-dependent protein kinase cannot be ruled 
out since the protein "Fraction K" was not characterized, Acti^ 
vation of a protein kinase (by high cyclic AMP levels) responsi­
ble for phosphorylation and inactivation of acetyl CoA carboxyl­
ase would be counter to the ^  novo synthesis of milk tri-
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glycerides during lactation. 
The rapid decline in cyclic AMP levels, noted here and 
elsewhere (Sapag-Hagar and Greenbaum 1973), at the time of 
parturition and lactogenesis and the continued decline through­
out lactation (Sapag-Hagar and Greenbaum 1973) are in accord 
with a repressive role of cyclic AMP on fatty acid synthesis. 
Cyclic GMP may play an important role in causing the 
decline in cyclic AMP levels noted from day 20 of pregnancy 
to day 1 of lactation, since adenylate cyclase activity has 
been reported to be enhanced by the presence of GTP. Theoret­
ically, then, an increase in guanylate cyclase activity would 
increase the conversion of GTP to cyclic GMP and would deplete 
the pool of cyclic GMP capable of interacting with the 
adenylate cyclase. Therefore,a decrease in GTP would also 
cause a decrease in the cyclic AMP output of the cell. 
Ionic fluxes within the mammary epithelial cell may be 
partly responsible for changes in the levels of cyclic nucleo-
tides at the onset of lactation. Ca has been shown to in­
hibit adenylate cyclase activity and to stimulate guanylate 
cyclase. The probable presence of increased intracellular 
Ca** during lactation could inhibit adenylate cyclase activity. 
Prolactin has been observed to increase the transport of ions 
across intestinal mucosa (Mainoya 1975) and, although the same 
effect has not been investigated in mammary epithelial cells, 
it seems to be a reasonable possibility. 
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Recently, oxytocin has been demonstrated to increase 
cyclic GMP levels in rat uteri (Goldberg et al. 1973b). Per­
haps an increase in the levels of circulating oxytocin at par­
turition and in response to suckling during lactation ate re­
sponsible for the elevated levels of cyclic GMP in the mammary 
gland during lactation. 
The preliminary test of this hypothesis reported here 
suggests that exogenous oxytocin is not involved in raising 
cyclic GMP levels within the mammary gland. However, more 
investigation is needed before completely ruling out the role 
of oxytocin. The 2,5 to 3-fold greater values for cyclic GMP 
assayed during this experiment suggest possible differences in 
technique (sodium pentobarbitol anesthesia) which I should 
reinvestigate before drawing conclusions. 
It is hard to determine from these data if cyclic nucleo­
tides play any significant rcls in mammary gland cell prolifer­
ation since cyclic AMP levels were observed to be both in­
creasing and decreasing at the same time that DNA wqs in­
creasing, Sapag-Hagar and Greenbaum (1973) essentially re­
ported the same results but subsequently reported (Sapag-
-3 
Hagar et al« 1974) that very high concentrations (10 M) of 
dibutyryl cyclic AMP significantly inhibited DNA and DNA syn­
thesis in rat mammary expiants. The high concentration of 
cyclic nucleotide used in their study, makes interpretation 
of the role of physiological levels of cyclic AMP on the control 
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of cell proliferation difficult. 
It appears from the data presented here and elsewhere 
(Sapag-Hagar and Greenbaum 1973) that control of cell prolif­
eration in the mammary glands is not the primary function of 
cyclic nucleotides. Also, there is a noticeable absence of 
any cell proliferation during the first few days of lactation 
which is contrary to some reports (Greenbaum and Slater 1957; 
Griffith and Turner 1961; Traurig 1967) but in agreement with 
Liu and Davis (1967). This could possibly be due to strain 
differences in the rats used for these investigations. 
Although the molecular control mechanisms of lactogenesis 
in the secretory cell remain obscure, the changes in cyclic 
nucleotide levels noted here are probably closely related to 
events directly preceding lactation. 
The reciprocal changes in cyclic AMP and cyclic GMP re­
ported here for the mammary gland at the time of parturition 
and lactogenesis are in accord with Goldberg's "dualism theory" 
for the two cyclic nucleotides. Points of speculation re­
garding differentiation of the mammary epithelial cell into a 
functional lactational cell, with respect to cellular cyclic 
nucleotide changes, might include the following; 
1. Differentiation of the epithelial cell involves the 
induction of proteins specific to milk such as 
casein and enzymes involved in lactose synthesis 
(galactosyl transferase and a-lactalbumin). The in­
duction of these proteins in mammary expants by 
prolactin has been reported to follow changes in the 
NHP fraction of nuclear proteins brought forth by 
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insulin administration and cell division and hydro-
cortisone-stimulated differentiation of daughter 
cells (Turkington et al. 1973). A continuing in­
crease in the amount of cyclic AMP-dependent protein 
kinase within the mammary tissue throughout pregnancy 
could possibly be due to hormonal stimulation of 
transcription of specific genes by prolactin during 
the last half of pregnancy (Majumder and Turkington 
1971). Protein kinase, activated throughout preg­
nancy by increased levels of cyclic AMP, is probably 
involved in a number of tissue-specific phosphoryla­
tion reactions including the phosphorylation of 
chromatin proteins and specific cellular enzymes. 
The phosphorylation of chromatin protein, usually 
thought to be associated with depression of genes, 
has been shown to be involved in repression of RNA 
polymerase activity in certain situations (Kleinsmith 
1975). Therefore, the phosphorylation of nuclear 
proteins by mammary gland cyclic AMP-dependent protein 
kinase noted by Kadohama and Turkington (1973) could 
possibly be involved in repressing the transcription 
of genes coding for lactational proteins. 
High cyclic AMP levels do not appear to be compatible 
with the activities of several enzymes in milk 
synthesis. The enzymes involved in fatty acid 
synthesis seem to be inhibited to the greatest extent 
by cyclic AMP (Sapag-Hagar et al. 1974) although the 
supraphysiological concentrations used to demonstrate 
inhibition leave room for question. 
Cyclic GMP and guanylate cyclase activity may be in­
volved in the modulation of intracellular cyclic AMP 
levels. These data are compatible with, although not 
proof of, such a role for cyclic GMP, A more complete 
investigation of the events occurring between day 20 
of pregnancy and day 1 of lactation would allow a 
better interpretation of the changes in cyclic nucleo­
tides over this period. 
Separate cyclic nucleotide-dependent protein kinases 
for the two cyclic nucleotides involved in the phos­
phorylation of separate substrates could be means 
of controlling differentiation especially if the 
specific substrates are DNA-associated proteins. 
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5. Changes in degradation of the cyclic nucleotides by 
specific phosphodiesterases is a possible explanation 
for changing amounts of assayable cyclic AMP and 
cyclic GMP in the mammary glands during pregnancy 
and lactation. Sapag-Hagar and Greenbaum (1973) 
noted an increase in cyclic AMP phosphodiesterase 
activity throughout lactation concommitant with a 
decrease in cyclic AMP. On the other hand, adenylate 
cyclase activity paralleled the decrease in cyclic 
AMP during lactation. Much less is known about the 
activities of guanylate cyclase and cyclic GMP 
phosphodiesterase, but cyclic GMP levels are almost 
certainly dependent on the levels and rates of 
activity of these two enzymes within the tissue. 
6. Although no clear evidence exists for direct media­
tion (of hormonal stimulation of the mammary gland 
at lactogenesis) by either cyclic AMP or cyclic GMP, 
there could possibly be indirect effects involving 
hormonal induction of specific cyclic nucleotide-
dependent proteins such as the protein kinase II of 
Majumder and Turkington (1971a), 
The role of cyclic nucleotides in controlling intracellu­
lar events associated with lactogenesis is unclear except for 
the observation that high levels of dibutyryl cyclic AMP are 
able to inhibit the activity of several constitutive enzymes 
in mammary expiants (Sapag-Hag^r et al. 1974). Even less di= 
rect evidence is available concerning the role of cyclic GMP 
in this process, however, the data, presented here suggest a 
possible antagonistic role for cyclic AMP and cyclic GMP in 
the regulation of cellular events in the rat mammary gland 
directly preceding lactation. 
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SUMMARY 
Mammary gland levels of RNA, DNA, cyclic AMP and cyclic 
GMP were assayed in rats on the 14th and 20th days of preg­
nancy and on the 1st and 3rd days of lactation. Mammary 
gland DNA levels and RNA;DNA ratios increased from day 14 
of pregnancy to day 1 of lactation; no change in either 
parameter was noted between the 1st and 3rd day of lacta­
tion. Cyclic AMP levels were observed to peak on the 20th 
day of pregnancy and to decline from day 20 of pregnancy to 
day 3 of lactation. Cyclic GMP levels were low on days 14 and 
20 of pregnancy and elevated on days 1 and 3 of lactation. 
The cyclic AMP;cyclic GMP ratio was elevated only on day 20 
of pregnancy while the ratio remained essentially unchanged 
on day 14 of pregnancy and days 1 and 3 of lactation. 
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APPENDIX A: NUCLEIC ACID ANALYSIS 
Removal of Lipids from 
Mammary Glands 
1. Immediately after removal of the six abdominal-inguinal 
mammary glands they are immersed in 50 ml of a solution 
of chloroform and methanol (2:1 by volume). 
2. The tissue is then minced with a scissors and kept in 
chloroform/methanol solution for 12 hours under constant 
mild agitation. 
3. The solvent is poured off and fresh chloroform/methanol 
(50 ml) is added to the minced tissue for another 12 hour 
extraction, again keeping under mild agitation. 
4. The chloroform/methanol is decanted off and ethyl ether 
(50 ml) is added to the minced tissue. Extract for 12 
hours with agitation. 
5. Pour off the ether and add a final 50 ml of ether and 
extract for another 12 hours under agitation. 
6= Pour off the ether and allow to air dry over night. 
7. Place the dried fat-freed tissue (DFPT) in an oven at 
50 C for two days, then place in a desiccator until 
ready for weighing. 
8. After the DPFT has been weighed, it is ground to a fine 
powder using a Wiley mill equipped with a number 40 sieve. 
9. The powdered DFFT is placed in an oven, again at 50 C 
for two days to insure dryness and then placed in a 
desiccator until ready for weighing samples for analysis. 
NOTE: Extraction times are not at all critical, change 
solutions in the morning and evening. Be sure DFPT 
powder is dry before weighing. 
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Procedure for Extracting Total 
Nucleic Acid 
1. 25 mg samples of DFFT (dry fat-free tissue) are suspended 
in 4.5-5 ml of 5% trichloroacetic acid (TCA) in thick 
walled, 12 ml volumetric centrifuge tubes. 
2. Allow the material to stand for two hours or until the 
tissue is saturated. Gently tap the tubes to cause the 
saturated DFFT to fall to the bottom of the tube. 
3. Then place the tubes in a 90 C water bath for exactly 15 
minutes. The tubes should be covered by glass marbles 
to reduce loss by evaporation. 
4. After removing the tubes from the hot water bath they 
are immediately transferred to a cold water bath. 
5. When cooled the tubes are centrifuged for 10-15 minutes 
at 3-4000 rpm. 
6. The supernatant is decanted into another volumetric 
centrifuge tube. 
7. The residue is resuspended with 4.5-5 ml of 5% TCA, placed 
in the 90 C water bath for exactly 15 minutes, and cooled 
as before. 
8. This second digest is centrifuged, and the decant combined 
with the decant from the first extraction. 
9. The combined extracts are then brought up to a volume of 
10 ml with 5% TCA. 
10, The extracts are then transferred to glass culture tubes 
for storage under refrigeration, until ready for analysis. 
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Preparation of Stock Hydrolyzed 
DNA and RNA Solutions 
Stock solutions of hydrolyzed DNA and RNA are prepared 
containing a concentration of 1 mg/ml. From these, dilu­
tions can be made for determinations of standard curves. 
The best procedure for preparing these is as follows: 
1. Place about 80 ml of 5% TCA in a 250 ml glass beaker. 
Put a teflon coated magnetic stirring bar in the beaker. 
2. Cover the top of the beaker with a double layer of thick 
aluminum foil. Poke a small hole in the center of the 
foil and insert a thermometer through the hole into the 
fluid. Place the therinometer at an angle so that it will 
not interfere with the stirring bar. 
3. Place this apparatus on a heated magnetic stirrer and 
heat the TCA solution to exactly 90 C. (Make sure you can 
maintain this temperature for a period of 15 minutes.) 
4. Pour 100 mg of DNA or RNA into the hot stirring TCA. 
After exactly 15 minutes from the time you put in the 
nucleic acid, the heaker is removed and placed in a cold 
water bath. 
5. The solution is then put into a 100 ml volumetric flask 
and filled to volume vrith 5% TCA. This stock can be 
stored under refrigeration for up to six months. 
6. To more accurately determine the concentration of these 
hydrolyzed standards a phosphorus content is determined 
as described in the Appendix, 
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Colorimetric Determination of 
DNA Content 
Preparation of reagents 
1. Diphenylamine reagent: 
This reagent should be prepared on the day it is to be 
used. Into 100 ml of A. R. glacial acetic acid (Baker's) 
is dissolved 1.5 g of reagent grade dipheylamine (use 
only Matheson, Coleman and Bell), and 1.5 ml of concen­
trated H5SO4. Just before use add 0.5 ml of aqueous 
acetaldenyde (16 mg/ml) to the reagent. 
2. Standard hydrolyzed DNA solutions: 
From the prepared stock hydrolyzed DNA solution make at 
least five different dilutions, the largest containing 
no more than 500 ug of DNA. 
3. IN perchloric acid: 
Add 9 ml of concentrated (70%) perchloric acid to 91 ml 
of glass distilled water. 
Method of color development 
1. 1 ml aliquots of nucleic acid extracts, as well as 
standards, are placed in test-tubes. To each tube is 
added 1 ml of 1 N perchloric acid and 4 ml of di­
phenylamine reagent. 
2. A blank is prepared by combining 1 ml of 5% TCA with 1 
ml of 1 N perchloric acid and 4 ml of diphenylamine 
reagent. 
3. Color is developed in the dark at room temperature 
for 16-20 hours. 
4. The absorbance is measured at 600 ma. 
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Calculations 
A standard curve is prepared by plotting the optical 
densities of the five DNA standards against their concentra­
tions. From this, the concentration of DNA in each of the 
extracts can be determined. Since standards and extracts 
were treated the same, no dilution corrections are necessary. 
Colorimetric Determination of 
RNA Content 
Preparation of reagents 
1. Orcinol reagent: 
Orcinol should be a white crystalline product. Only 
orcinol purchased from Calbiochem was found suitable 
for use without purification. 
A solution of 0.5 g of FeClo per 100 ml of concentrated 
HCl is prepared, which can oe stored indefinitely. 
Immediately before use, 1 g of orcinol is added per 
100 ml of solution. 
2. Standard dilutions of both the hydrolyzed DNA and RNA 
stock solutions are required. Have five dilutions of 
each, the largest dilution having no more than 500 ug 
DNA or RNA. 
Method of color development 
1. 0.5 ml aliguots of nucleic acid extracts, as well as 0.5 
ml aliquets of both DNA and RNA standards, are placed in 
test-tubes. To each test-tube is added 2 ml of 5% 
TCA and 2.5 ml of orcinol reagent. 
2. A blank is prepared by mixing 2.5 ml of 5% TCA with 2.5 
ml of orcinol reagent. 
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3. Place tubes in a hot water bath (95 C) for exactly 20 
minutes. Have marbles on the tubes to prevent loss 
from evaporation. 
4. Cool the tubes in a cold water bath. 
5. The absorbance is measured at 660 mu. 
Calculations 
Two standard curves must be prepared; one for the DNA 
standards and one for the RNA standards. Orcinol reacts with 
DNA as well as RNA, although to a much lesser extent. Never­
theless, in each sample a correction must be made for the 
fraction of the total optical density measured which was 
due to the presence of DNA in the extract. This is done as 
follows: 
1= A standard curve is prepared plotting the optical densi­
ties of the DNA standards against their concentrations. 
2. Having previously determined DNA by the diphenylamine 
method, the amount of DNA present in each of the 0.5 ml 
aliguots can be calculated. This means a separate calcu­
lation must be made for each sample. 
3. From the above standard curve it can be determined how 
much optical density will result from the amount of DNA 
in the aliquot. 
4. This calculated optical density due to DNA must be sub­
tracted from the total optical density obtained from! the 
spectrophotometer. The remaining optical density, then, 
is that due to the RNA present in the 0.5 ml aliquot. 
(The "corrected" optical density.) 
5. A standard curve is made plotting optical density of the 
RNA standards against their concentration. 
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6. Using this standard curve the concentration of RNA in 
each sample can be determined from the "corrected" 
optical densities. 
Procedure for the Analysis of Nucleic Acid Content 
by Colorimetric Determination of Phosphorous 
Preparation of reagents and solutions 
1. Standard phosphate: 
A stock solution of monopotassium phosphate is made which 
contains 80 ug of phosphorus per ml. Into a liter volu­
metric flask dissolve 0.3509 g of monopotassium phosphate 
in water, add 10 ml of 10 N sulfuric acid, and dilute to 
the mark with distilled water. (It is suggested that 
glass distilled water be used throughout the procedure.) 
Make four dilutions from the stock; 40 ug/ml, 20 ug/ml, 
10 ug/ml, 5 ug/ml. 
2. Molybdate (ACID) reagent: 
Dissolve 25 g of ammonium molybdate in 200 ml distilled 
water. Rinse into a liter volumetric flask containing 
500 ml of 10 N Sulfuric acid, and dilute to mark with 
water. Store in a wax lined bottle under refrigeration. 
3. Molybdate reagent: 
Dissolve 25 g of ammonium molybdate in a liter of dis­
tilled water. Store in a wax lined bottle under refriger­
ation. 
4. Amino-napthol-sulfonic acid reagent (ANS): 
This reagent can be bought pre-mixed in dry form from 
Harleco (Hartman-Leddon Company), item number 52532. 
Prepare according to manufacturer's instructions. 
Prepare stock solutions of 5 N and 10 N. 
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Determination of standard curve 
Color development of the standard phosphate solutions is 
carried out in 50 ml volumetric flasks according to the 
following procedures; 
1. Add 5 ml of standard phosphate solution. 
2. Add 30 ml of distilled water. 
3. Add 5 ml of molybdate (ACID) reagent. 
4. Add 2 ml of ANS reagent. 
5. Mix - dilute to mark with water - mix again. 
6. Let stand for 5 minutes and immediately measure 
against a blank at 700 mu. 
A blank is prepared in exactly the same way, except that the 
5 ml of standard phosphate is replaced by another 5 ml of dis­
tilled water. 
From this, a standard curve relating phosphorous con­
centration to absorbance can be made. 
Determination of nucleic acid phosphorus content 
Assuming DNA and RNA standards have been prepared by 
hydrolysis in 5% TCA, the procedure for determining phosphorus 
content is outlined as follows: 
1. Into a large lipped Pyrex test-tube (200 mm x 25 mm) 
add 5 ïûl of the stock nucleic acid solution to 5 ml 
of, 5 N sulfuric acid. 
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2. Put about three glass boiling beads in the mixture 
and boil under a microburner. When the solution has 
boiled down to about a milliliter or two, a dense 
fume will appear and the solution turns yellow. When 
this occurs, turn the flame down low but do not let 
the boiling stop. The solution will get progressive­
ly darker and when there is no further blackening, 
add one drop of nitric acid so that it runs down the 
wall of the test-tube. This should eliminate most 
of the color. Add another drop if necessary, but do 
not add an excess. Continue boiling for about 30 
seconds to remove all the nitric acid. 
3. Remove from heat and allow it to cool down slightly; 
then put it under the tap to further cool it. 
(Caution) This procedure should be performed under the hood. 
If at any time the solution stops boiling, turn up 
the flame slightly while agitating the solution 
until boiling again begins. If you do not agitate, 
it will superheat and spurt out. 
4. Empty the contents into a 50 ml volumetric flask. 
Wash the test-tube three times with 10 ml of distilled 
water per washing. Pour the washing into the flask. 
5. Add 5 ml of molybdate reagent and 2 ml of ANS 
reagent. 
6. Mix - fill to volume - mix. 
7. Let stand for 5 minutes, then immediately measure 
the absorbance against a blank at 700 mu. 
A blank is prepared by mixing the same reagents, replacing the 
5 ml of nucleic acid solution with 5 ml of 5% TCA. The boil­
ing procedure can be eliminated. 
Comparison of the absorbance measured in the nucleic acid 
solution with the standard curve will give the concentration 
of phosphorus. Concentrations of DNA and RNA can then be 
estimated by assuming that phosphorus is 10% of the weight 
of the nucleic acid. 
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APPENDIX B: CYCLIC NUCLEOTIDE ANALYSIS 
Preparation of Tissue Samples for 
Cyclic Nucleotide Analysis 
1. Freeze tissue in liquid nitrogen immediately after 
recovery and store at -76 C. 
2. Weigh out 5-10 mg (cAMP assay) or 100-150 mg (cGMP 
assay) of tissue and homogenize in 500 yl 6% tri­
chloroacetic acid at 4 C. 
3. Centrifuge homogenates at 1500 rpm at 4 C. for 
30 minutes and recover the supernatant. 
4. Extract the supernatant three times with 10 volumes of 
ethyl ether saturated with water. 
5. Concentrate aqueous solution to dryness in a stream of 
air. Keep in 60-70 C. water bath during concentration. 
6. Dissolve the residue in 1.0 ml sodium acetate buffer, 
pH 6.2. 
7. Take 100 yl (cAMP assay) or 300 pi (cGMP assay) of 
reconstituted solution for radioimmunoassay. 
NOTE; Because of the extremely small amounts of cyclic GMP de­
tected in the mammary tissue samples, it was thought 
nscssssry to tsst ths 5ss«y usxng s tissue repotted 
to have relatively high concentrations of this cyclic 
nucleotide, i.e. lung. Rat lung tissue cyclic GMP was 
in the range of 40-50 p mol/g wet tissue which is 5-10 
times the mammary tissue levels and within the reported 
range for rat lung (Goldberg et al. 1973a), Therefore, 
to obtain an accurate assay for cyclic GMP in the mammary 
gland, the amount of tissue assayed was increased from 
approximately 50 mg to approximately 150 mg. 
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The Assay 
Standard curves are prepared from stock standard solu­
tions provided in each kit. The range of the standard curve 
for the cyclic AMP is 0.025-10.0 p mol. The range for the 
cyclic GMP assay is 0,1-10.0 p mol. In addition, each set of 
standards includes; 1) a "blank" tube, which represents 
125 the amount of I-cyclic nucleotide "sticking" to the side 
of the assay tube in the absence of antiserum, 2) a "trace" 
1 nc 
tube which represents the amount of I-cyclic nucleotide 
bound to antiserum in the absence of unlabeled cyclic 
nucleotide, and 3) a "total count" tube containing 100 
125 
yl I-cyclic nucleotide. 
Assay tubes are set up in triplicate according to the 
following procedure: 
1. 
2 .  
NOTE: The total volume after steps 1 and 2 should be 300 yl. 
The amount of sodium acetate buffer added is dictated 
by step 2. 
Pipet sodium acetate buffer into tubes.^ 
Pipet appropriate amount (100 yl for cAMP assay; 
300 yl for cGMP) of sample into tubes.^ 
^In the cyclic AMP assay. 
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3. Add 100 lil labeled cyclic nucleotide. Mix 
well. 
4. Add 100 yl cyclic nucleotide antiserum. Mix 
well. 
5. Shake rack of tubes well. Cover rack of tubes with 
foil, 
6. Refrigerate at 2-4 C. for 18 hours. 
7. Transfer tubes to an ice bath. 
8. Add 2.5 ml 60% saturated ammonium sulfate to each 
tube. Mix using a Vortex mixer. 
9. Keep tubes in ice bath for 10 minutes. 
10. Centrifuge tubes at 2000 rpm at 4 C. for one hour, 
preferably using a swinging bucket rotor. 
11. Decant off and discard supernatants. Retaining 
the tube at a downward angle, remove additional 
supernatant by swabbing with a cotton tipped appli­
cator, 
12= The tubes are then counted for 5 min, on a solid 
crystal scintillation counter. 
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Calculations 
1. Subtract the "Blank" cpm from cpm from each of the 
tubes. 
2. The standard curve is calculated either on the basis 
of per cent of total count bound (standard counts/ 
total counts) vs concentration^ or percent of trace 
binding (standard counts/trace counts) versus con­
centration.2 
3. The amount of cyclic nucleotide in each sample tube 
then read directly from the standard curve. 
4. The cyclic nucleotides per milligram of tissue for 
each sample is calculated by the following formula: 
cyclic nucleotide _ amount of cyclic 1.0 ml 
mg tissue nucleotide in tube ml of aliquot 
^ mg tissue 
homogen 
5. Total cyclic nucleotide in 3 abdominal inguinal 
mammary glands is calculated. 
cyclic nucleotide mg wet weight of 3 abdominal-
mg tissue inguinal mammary glands 
^In the cyclic AMP assay. 
^In the cyclic GMP assay. 
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